Krebs Biochemicals & Industries Ltd share price logo

Krebs Biochemicals & Industries Ltd (KREBSBIO)

₹98.311.85%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹95.15
    ₹101.96
  • 52 Week's Low

    52 Week's High

    ₹60.35
    ₹121.55
1 Month Return+ 42.05 %
3 Month Return+ 38.73 %
1 Year Return+ 44.43 %
Previous Close₹100.16
Open₹101.96
Volume28.15K
Upper Circuit-
Lower Circuit-
Market Cap₹215.95Cr

Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹215.95 Cr
P/B Ratio-1.22
EPS0

Company Information

Krebs Biochemicals Industries Ltd. (KBIL) is a fermentation-based active pharmaceutical ingredient (API) manufacturer. Established in 1991, KBL has grown to a capacity of 150 TPA since launching its commercial operations in 1994. KBL has developed global capabilities in fermentation technology, resulting in successful launches over a two-year period (200102) of Vitamin CIP Grade via fermentation. The company has ISO 9002 certifications for its unit I at Nellore and produces and markets Lovastatin, Simvastatin, and Vitamin C. KBL is also in the process of building a cogeneration power plant at unit II. It has also successfully bidded for Nannapaneni Venkatrao Cooperative Sugars Ltd located at Jampani, Guntur District, Andhra Pradesh in December 2003.

Share Price: ₹98.31 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹215.95Cr as of today
Listing date: 28 Aug, 1995
Chairperson Name: R T Ravi
OrganisationKrebs Biochemicals & Industries Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals Reports Q4 Results - 24 May, 2024

    Krebs Biochemicals & Industries reported its Q4 results with a YoY increase in revenue and a decrease in loss. However, there was a decline in revenue and an increase in loss compared to the previous quarter. The company's market cap is ₹143.38 Cr with negative returns over the last 6 months and year-to-date.

  • Krebs Biochem Reports 4.47% YoY Growth in Net Sales - 22 May, 2024

    Krebs Biochemicals & Industries Ltd reports a 4.47% YoY growth in net sales for March 2024, with quarterly net loss at Rs. 5.85 crore and negative EBITDA of Rs. 2.91 crore. The stock has given -12.64% returns over the last 6 months and 5.80% over the last 12 months.

Insights on Krebs Biochemicals & Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, KREBSBIO stock has moved up by 42.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.74% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 26.76% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 146.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 42.7%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.49% of holdings in Jun 2024 quarter

Company Financials

Value in ₹ crore
2023Y/Y Change
Total Assets
₹174.98Cr
↓7.81%
Total Liabilities
₹144.44Cr
↑7.07%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
-₹24.71Cr
↑43.50%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
72.74%
0.00
Foreign Institutions
0.49%
0.00
Mutual Funds
0%
0.00
Retail Investors
26.76%
0.00
Others
0%
0.00

Earnings and Dividends

  • Krebs Biochemicals & Industries Ltd Earnings Results

    Krebs Biochemicals & Industries Ltd’s net profit jumped 15.71% since last year same period to ₹-5.85Cr in the Q4 2023-2024. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated -17.47% fall in its net profits since last 3-months.

    Read More about Earnings Results

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Krebs Biochemicals & Industries Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Krebs Biochemicals & Industries Ltd shares.

Krebs Biochemicals & Industries Ltd (KREBSBIO) share price today is ₹98.31

Krebs Biochemicals & Industries Ltd is listed on NSE

Krebs Biochemicals & Industries Ltd is listed on BSE

  • Today’s highest price of Krebs Biochemicals & Industries Ltd is ₹101.96.
  • Today’s lowest price of Krebs Biochemicals & Industries Ltd is ₹95.15.

Today’s traded volume of Krebs Biochemicals & Industries Ltd(KREBSBIO) is 28.15K.

Today’s market capitalisation of Krebs Biochemicals & Industries Ltd(KREBSBIO) is ₹215.95Cr.

Krebs Biochemicals & Industries Ltd(KREBSBIOPrice
52 Week High
₹121.55
52 Week Low
₹60.35

Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹98.31. It is down -19.12% from its 52 Week High price of ₹121.55

Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹98.31. It is up 62.90% from its 52 Week Low price of ₹60.35

Krebs Biochemicals & Industries Ltd(KREBSBIOReturns
1 Day Returns
-1.85%
1 Month Returns
42.05%
3 Month Returns
38.73%
1 Year Returns
44.43%